Melatonin signaling in mouse cerebellar granule cells with variable native MT1 and MT2 melatonin receptors

[1]  R. Xiu,et al.  Intracellular signaling pathways involved in cell growth inhibition of human umbilical vein endothelial cells by melatonin , 2007, Journal of pineal research.

[2]  D. Swaab,et al.  Decreased MT1 melatonin receptor expression in the suprachiasmatic nucleus in aging and Alzheimer's disease , 2007, Neurobiology of Aging.

[3]  Josep M. Guerrero,et al.  Evidence for melatonin synthesis in the rat brain during development , 2007, Journal of pineal research.

[4]  D. Swaab,et al.  Distribution of MT1 melatonin receptor immunoreactivity in the human hypothalamus and pituitary gland: Colocalization of MT1 with vasopressin, oxytocin, and corticotropin‐releasing hormone , 2006, The Journal of comparative neurology.

[5]  Nicholas M. Radio,et al.  Therapeutic treatments potentially mediated by melatonin receptors: potential clinical uses in the prevention of osteoporosis, cancer and as an adjuvant therapy , 2006, Journal of pineal research.

[6]  R. Ravid,et al.  Pineal and cortical melatonin receptors MT1 and MT2 are decreased in Alzheimer's disease. , 2006, European journal of histochemistry : EJH.

[7]  Nicholas M. Radio,et al.  Melatonin enhances alkaline phosphatase activity in differentiating human adult mesenchymal stem cells grown in osteogenic medium via MT2 melatonin receptors and the MEK/ERK (1/2) signaling cascade , 2006, Journal of pineal research.

[8]  L. Palinkas,et al.  Urinary melatonin: a noninvasive method to follow human pineal function as studied in three experimental conditions , 2006, Journal of pineal research.

[9]  J. Larson,et al.  Impaired hippocampal long-term potentiation in melatonin MT2 receptor-deficient mice , 2006, Neuroscience Letters.

[10]  Yogesh K. Dwivedi,et al.  The regional and cellular expression profile of the melatonin receptor MT1 in the central dopaminergic system. , 2005, Brain research. Molecular brain research.

[11]  M. Dubocovich,et al.  The antidepressant‐like effect of the melatonin receptor ligand luzindole in mice during forced swimming requires expression of MT2 but not MT1 melatonin receptors , 2005, Journal of pineal research.

[12]  S. Hinuma,et al.  Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist , 2005, Neuropharmacology.

[13]  E. Kılıç,et al.  Signal transduction pathways involved in melatonin‐induced neuroprotection after focal cerebral ischemia in mice , 2005, Journal of pineal research.

[14]  R. Ravid,et al.  Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease , 2005, Journal of pineal research.

[15]  P. Delagrange,et al.  Preferential Formation of MT1/MT2 Melatonin Receptor Heterodimers with Distinct Ligand Interaction Properties Compared with MT2 Homodimers , 2004, Molecular Pharmacology.

[16]  M. Dubocovich,et al.  Molecular pharmacology, regulation and function of mammalian melatonin receptors. , 2003, Frontiers in bioscience : a journal and virtual library.

[17]  D. Abramovich,et al.  Melatonin receptors in human fetal brain: 2‐[125I]iodomelatonin binding and MT1 gene expression , 2002, Journal of pineal research.

[18]  P. Fossier,et al.  Monitoring of Ligand-independent Dimerization and Ligand-induced Conformational Changes of Melatonin Receptors in Living Cells by Bioluminescence Resonance Energy Transfer* 210 , 2002, The Journal of Biological Chemistry.

[19]  T. Voyno-Yasenetskaya,et al.  Melatonin mt1 and MT2 receptors stimulate c-Jun N-terminal kinase via pertussis toxin-sensitive and -insensitive G proteins. , 2002, Cellular signalling.

[20]  R. Ravid,et al.  Increased melatonin 1a‐receptor immunoreactivity in the hippocampus of Alzheimer's disease patients , 2002, Journal of pineal research.

[21]  H. Manev,et al.  5-Lipoxygenase is required for proliferation of immature cerebellar granule neurons in vitro. , 2001, European journal of pharmacology.

[22]  M. Melan,et al.  N1E-115 mouse neuroblastoma cells express MT1 melatonin receptors and produce neurites in response to melatonin. , 2001, Biochimica et biophysica acta.

[23]  A. Strosberg,et al.  Differential signaling of human Mel1a and Mel1b melatonin receptors through the cyclic guanosine 3'-5'-monophosphate pathway. , 1999, Biochemical pharmacology.

[24]  M. Dubocovich,et al.  Melatonin receptor subtype expression in human cerebellum. , 1998, Neuroreport.

[25]  M. Dubocovich,et al.  Physiological exposure to melatonin supersensitizes the cyclic adenosine 3',5'-monophosphate-dependent signal transduction cascade in Chinese hamster ovary cells expressing the human mt1 melatonin receptor. , 1998 .

[26]  H. Manev,et al.  Protective effect of melatonin against hippocampal dna damage induced by intraperitoneal administration of kainate to rats , 1996, Neuroscience.

[27]  H. Manev,et al.  Melatonin protects primary cultures of cerebellar granule neurons from kainate but not from N-methyl-d-aspartate excitotoxicity , 1995, Experimental Neurology.

[28]  H. Manev,et al.  Is the heterologous expression of metabotropic glutamate receptors (mGluRs) an appropriate method to study the mGluR function? Experience with human embryonic kidney 293 cells transfected with mGluR1 , 1994, Neurochemistry International.

[29]  C. Nordin,et al.  Serum and cerebrospinal fluid concentrations of melatonin: a pilot study in healthy male volunteers , 1999, Journal of Neural Transmission.